Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,120.59
1,172.08
1,012.76
931.37
1,322.36
2,076.60
2,134.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,120.59
1,172.08
1,012.76
931.37
1,322.36
2,076.60
2,134.80
Raw Material Cost
592.35
518.31
413.20
357.00
533.58
548.20
386.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
269.49
270.83
174.86
170.79
160.68
172.10
149.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
27.29
24.08
23.56
14.59
9.51
4.83
2.06
Selling and Distribution Expenses
402.70
566.18
560.11
634.91
709.38
1,260.43
1,522.90
Other Expenses
-20.07
-19.48
-12.16
-9.95
-7.14
-7.58
-8.31
Total Expenditure (Excl Depreciation)
1,091.11
1,184.56
1,050.15
1,077.78
1,341.73
1,909.73
1,977.35
Operating Profit (PBDIT) excl Other Income
29.5
-12.5
-37.400000000000006
-146.4
-19.4
166.9
157.5
Other Income
39.48
61.78
40.13
592.40
99.54
58.98
95.16
Operating Profit (PBDIT)
188.72
167.64
118.38
545.76
175.55
305.26
325.02
Interest
27.29
24.08
23.56
14.59
9.51
4.83
2.06
Exceptional Items
-14.49
16.02
13.22
-5.15
-37.14
15.79
6.04
Gross Profit (PBDT)
528.23
653.77
599.56
574.37
788.78
1,528.40
1,748.50
Depreciation
116.67
114.02
110.34
103.16
91.16
82.53
75.22
Profit Before Tax
30.26
45.56
-2.29
422.87
37.74
233.70
253.78
Tax
5.03
11.30
13.57
103.18
6.52
54.36
44.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
58.68
73.66
30.21
350.95
29.32
177.18
205.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
58.68
73.66
30.21
350.95
29.32
177.18
205.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.70
-3.58
-3.71
-1.27
-2.69
-3.32
-1.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
54.98
70.08
26.50
349.68
26.63
173.86
204.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,160.12
2,140.49
2,040.86
2,101.45
1,775.28
1,832.70
1,943.82
Earnings per share (EPS)
0.19
0.24
0.1
1.13
0.09
0.57
0.65
Diluted Earnings per share
0.19
0.24
0.1
1.13
0.09
0.57
0.65
Operating Profit Margin (Excl OI)
2.91%
-0.7%
-3.17%
-16.08%
-1.14%
7.89%
7.24%
Gross Profit Margin
13.11%
13.62%
10.67%
56.48%
9.75%
15.23%
15.41%
PAT Margin
5.24%
6.28%
2.98%
37.68%
2.22%
8.53%
9.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -4.39% vs 15.73% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -21.54% vs 164.53% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 40.89% vs 35.25% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 13.28% vs 2.12% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Harbin Medisan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,120.59
0
1,120.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,120.59
0
1,120.59
Raw Material Cost
592.35
0
592.35
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
269.49
0
269.49
Power Cost
0
0
0.00
Manufacturing Expenses
27.29
0
27.29
Selling and Distribution Expenses
402.70
0
402.70
Other Expenses
-20.07
0.00
-20.07
Total Expenditure (Excl Depreciation)
1,091.11
0
1,091.11
Operating Profit (PBDIT) excl Other Income
29.48
0.00
29.48
Other Income
39.48
0
39.48
Operating Profit (PBDIT)
188.72
0
188.72
Interest
27.29
0
27.29
Exceptional Items
-14.49
0
-14.49
Gross Profit (PBDT)
528.23
0
528.23
Depreciation
116.67
0
116.67
Profit Before Tax
30.26
0
30.26
Tax
5.03
0
5.03
Provisions and contingencies
0
0
0.00
Profit After Tax
58.68
0
58.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
58.68
0
58.68
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.70
0
-3.70
Other related items
0.00
0.00
0.00
Consolidated Net Profit
54.98
0
54.98
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,160.12
0
2,160.12
Earnings per share (EPS)
0.19
0
0.19
Diluted Earnings per share
0.19
0
0.19
Operating Profit Margin (Excl OI)
2.91%
0%
0.00
2.91%
Gross Profit Margin
13.11%
0%
0.00
13.11%
PAT Margin
5.24%
0%
0.00
5.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 112.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -4.39% vs 15.73% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 5.50 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -21.54% vs 164.53% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.92 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.89% vs 35.25% in Dec 2023
Annual - Interest
Interest 2.73 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 13.28% vs 2.12% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.91%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






